The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus

Brian N. Finck, John J. Lehman, Teresa C. Leone, Michael J. Welch, Michael J. Bennett, Attila Kovacs, Xianlin Han, Richard W. Gross, Ray Kozak, Gary D. Lopaschuk, Daniel P. Kelly

Research output: Contribution to journalArticle

673 Citations (Scopus)

Abstract

Recent evidence has defined an important role for PPARα in the transcriptional control of cardiac energy metabolism. To investigate the role of PPARα in the genesis of the metabolic and functional derangements of diabetic cardiomyopathy, mice with cardiac-restricted overexpression of PPARα (MHC-PPAR) were produced and characterized. The expression of PPARα target genes involved in cardiac fatty acid uptake and oxidation pathways was increased in MHC-PPAR mice. Surprisingly, the expression of genes involved in glucose transport and utilization was reciprocally repressed in MHC-PPAR hearts. Consistent with the gene expression profile, myocardial fatty acid oxidation rates were increased and glucose uptake and oxidation decreased in MHC-PPAR mice, a metabolic phenotype strikingly similar to that of the diabetic heart. MHC-PPAR hearts exhibited signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and transgene expression-dependent alteration in systolic ventricular dysfunction. These results demonstrate that (a) PPARα is a critical regulator of myocardial fatty acid uptake and utilization, (b) activation of cardiac PPARα regulatory pathways results in a reciprocal repression of glucose uptake and utilization pathways, and (c) derangements in myocardial energy metabolism typical of the diabetic heart can become maladaptive, leading to cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)121-130
Number of pages10
JournalJournal of Clinical Investigation
Volume109
Issue number1
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Peroxisome Proliferator-Activated Receptors
Diabetes Mellitus
Phenotype
Diabetic Cardiomyopathies
Fatty Acids
Glucose
Energy Metabolism
Ventricular Dysfunction
Transgenes
Cardiomyopathies
Transcriptome
Hypertrophy
Transcriptional Activation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., ... Kelly, D. P. (2002). The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation, 109(1), 121-130. https://doi.org/10.1172/JCI0214080

The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. / Finck, Brian N.; Lehman, John J.; Leone, Teresa C.; Welch, Michael J.; Bennett, Michael J.; Kovacs, Attila; Han, Xianlin; Gross, Richard W.; Kozak, Ray; Lopaschuk, Gary D.; Kelly, Daniel P.

In: Journal of Clinical Investigation, Vol. 109, No. 1, 01.01.2002, p. 121-130.

Research output: Contribution to journalArticle

Finck, BN, Lehman, JJ, Leone, TC, Welch, MJ, Bennett, MJ, Kovacs, A, Han, X, Gross, RW, Kozak, R, Lopaschuk, GD & Kelly, DP 2002, 'The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus', Journal of Clinical Investigation, vol. 109, no. 1, pp. 121-130. https://doi.org/10.1172/JCI0214080
Finck, Brian N. ; Lehman, John J. ; Leone, Teresa C. ; Welch, Michael J. ; Bennett, Michael J. ; Kovacs, Attila ; Han, Xianlin ; Gross, Richard W. ; Kozak, Ray ; Lopaschuk, Gary D. ; Kelly, Daniel P. / The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. In: Journal of Clinical Investigation. 2002 ; Vol. 109, No. 1. pp. 121-130.
@article{9ed9bbc6379f4127937737b2e3b94a4e,
title = "The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus",
abstract = "Recent evidence has defined an important role for PPARα in the transcriptional control of cardiac energy metabolism. To investigate the role of PPARα in the genesis of the metabolic and functional derangements of diabetic cardiomyopathy, mice with cardiac-restricted overexpression of PPARα (MHC-PPAR) were produced and characterized. The expression of PPARα target genes involved in cardiac fatty acid uptake and oxidation pathways was increased in MHC-PPAR mice. Surprisingly, the expression of genes involved in glucose transport and utilization was reciprocally repressed in MHC-PPAR hearts. Consistent with the gene expression profile, myocardial fatty acid oxidation rates were increased and glucose uptake and oxidation decreased in MHC-PPAR mice, a metabolic phenotype strikingly similar to that of the diabetic heart. MHC-PPAR hearts exhibited signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and transgene expression-dependent alteration in systolic ventricular dysfunction. These results demonstrate that (a) PPARα is a critical regulator of myocardial fatty acid uptake and utilization, (b) activation of cardiac PPARα regulatory pathways results in a reciprocal repression of glucose uptake and utilization pathways, and (c) derangements in myocardial energy metabolism typical of the diabetic heart can become maladaptive, leading to cardiomyopathy.",
author = "Finck, {Brian N.} and Lehman, {John J.} and Leone, {Teresa C.} and Welch, {Michael J.} and Bennett, {Michael J.} and Attila Kovacs and Xianlin Han and Gross, {Richard W.} and Ray Kozak and Lopaschuk, {Gary D.} and Kelly, {Daniel P.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1172/JCI0214080",
language = "English (US)",
volume = "109",
pages = "121--130",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus

AU - Finck, Brian N.

AU - Lehman, John J.

AU - Leone, Teresa C.

AU - Welch, Michael J.

AU - Bennett, Michael J.

AU - Kovacs, Attila

AU - Han, Xianlin

AU - Gross, Richard W.

AU - Kozak, Ray

AU - Lopaschuk, Gary D.

AU - Kelly, Daniel P.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Recent evidence has defined an important role for PPARα in the transcriptional control of cardiac energy metabolism. To investigate the role of PPARα in the genesis of the metabolic and functional derangements of diabetic cardiomyopathy, mice with cardiac-restricted overexpression of PPARα (MHC-PPAR) were produced and characterized. The expression of PPARα target genes involved in cardiac fatty acid uptake and oxidation pathways was increased in MHC-PPAR mice. Surprisingly, the expression of genes involved in glucose transport and utilization was reciprocally repressed in MHC-PPAR hearts. Consistent with the gene expression profile, myocardial fatty acid oxidation rates were increased and glucose uptake and oxidation decreased in MHC-PPAR mice, a metabolic phenotype strikingly similar to that of the diabetic heart. MHC-PPAR hearts exhibited signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and transgene expression-dependent alteration in systolic ventricular dysfunction. These results demonstrate that (a) PPARα is a critical regulator of myocardial fatty acid uptake and utilization, (b) activation of cardiac PPARα regulatory pathways results in a reciprocal repression of glucose uptake and utilization pathways, and (c) derangements in myocardial energy metabolism typical of the diabetic heart can become maladaptive, leading to cardiomyopathy.

AB - Recent evidence has defined an important role for PPARα in the transcriptional control of cardiac energy metabolism. To investigate the role of PPARα in the genesis of the metabolic and functional derangements of diabetic cardiomyopathy, mice with cardiac-restricted overexpression of PPARα (MHC-PPAR) were produced and characterized. The expression of PPARα target genes involved in cardiac fatty acid uptake and oxidation pathways was increased in MHC-PPAR mice. Surprisingly, the expression of genes involved in glucose transport and utilization was reciprocally repressed in MHC-PPAR hearts. Consistent with the gene expression profile, myocardial fatty acid oxidation rates were increased and glucose uptake and oxidation decreased in MHC-PPAR mice, a metabolic phenotype strikingly similar to that of the diabetic heart. MHC-PPAR hearts exhibited signatures of diabetic cardiomyopathy including ventricular hypertrophy, activation of gene markers of pathologic hypertrophic growth, and transgene expression-dependent alteration in systolic ventricular dysfunction. These results demonstrate that (a) PPARα is a critical regulator of myocardial fatty acid uptake and utilization, (b) activation of cardiac PPARα regulatory pathways results in a reciprocal repression of glucose uptake and utilization pathways, and (c) derangements in myocardial energy metabolism typical of the diabetic heart can become maladaptive, leading to cardiomyopathy.

UR - http://www.scopus.com/inward/record.url?scp=0036143320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036143320&partnerID=8YFLogxK

U2 - 10.1172/JCI0214080

DO - 10.1172/JCI0214080

M3 - Article

VL - 109

SP - 121

EP - 130

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -